市場調查報告書
商品編碼
1248113
全球消融設備市場——按技術、應用、最終用途和預測劃分,2023-2032 年Ablation Devices Market - By Technology, By Application, By End-use & Global Forecast, 2023 - 2032 |
全球消融設備市場預計將從 2023 年到 2032 年顯著增長,這要歸功於該行業不斷創新以提高準確性並提供更好的結果。
2023年,i-VASC宣布首次臨床使用VELEX,這是一種用於治療慢性靜脈功能不全的空靜脈消融技術設備。
這些企業集團還投資於研發活動以開發和推出新產品,從而提高了產品供應率。 例如,2023年2月,雅培的兩款電生理產品在歐美獲得監管批准,用於治療心房顫動等心律失常患者,一款帶有尖端和接觸力感應的消融導管獲得CE標誌(AFib)。
該公司還聲稱,TactiFlex 消融導管 SE 可以更輕鬆地適應心臟組織,同時提供高功率消融治療。 與傳統的功率消融相比,它已被證明可以減少手術時間和患者的輻射暴露。
消融設備行業按技術、應用、最終用途和地理位置進行細分。
就技術而言,到 2032 年,激光/光學燒蝕行業的價值預計將超過 21 億美元。 發達國家和發展中國家老齡化人口的持續增加預計將增加對激光/光消融設備的需求。 與使用激光消融設備相關的主要優勢,例如高效性和安全性,也將推動這一領域的增長。
根據應用,預計眼科領域在估計期間的複合年增長率將超過 9%。 2023 年至 2032 年期間,技術的不斷發展和先進設備的普及以及為各種眼疾提供治療的設備齊全的設施將推動該領域的擴張。
考慮到最終用途,預計其他部分在預測期內將顯著增長。 其他部門包括獨立的導管實驗室、診所、多學科中心和消融中心。 對為一系列醫療條件提供專門治療和高質量護理的多專科中心的需求正在增加,我們預計到 2032 年底該行業將獲得發展勢頭。
按地區劃分,到 2032 年,歐洲消融設備行業的價值預計將超過 55 億美元。 易患慢性病的老年人口不斷增加,推動了該地區對消融設備的需求。 此外,可支配收入的增加和創新技術的採用預計將在預計期間進一步推動歐洲消融設備市場的增長。
Ablation Devices Market is estimated to grow considerably during 2023-2032 owing to the constant technological innovations in the industry to offer enhanced precision and better outcomes. In 2023, I-VASC announced the 1st clinical use of VELEX, the Empty Vein Ablation technology device for chronic venous insufficiency treatment.
These conglomerates are also investing in research and development activities for new product development and launches, thus positively expanding the product availability ratio. For instance, in February 2023, regulatory approval was granted for two of Abbott's electrophysiological products in Europe and the U.S. for treating patients with irregular cardiac rhythms like atrial fibrillation, Abbott's Sensor Enabled TactiFlex Ablation Catheter, an ablation catheter with an adaptable tip and contact force sensing, received the CE mark (AFib).
Also, according to the company, the TactiFlex Ablation Catheter SE can give high-power ablation treatment while more readily adjusting to the heart tissue. It has been demonstrated to shorten operation times and patient radiation exposure compared to traditional power ablation.
Overall, the ablation device industry is segmented in terms of technology, application, end-use and region.
Based on technology, the laser/light ablation segment is anticipated to be valued at over USD 2.1 billion by 2032. The constantly growing geriatric population base in developed and developing nations is expected to push the demand for laser/light ablation devices. In addition, key advantages linked with using laser ablation devices, such as high efficacy and safety, will also drive the segmental growth.
By application, the ophthalmology segment will depict over 9% CAGR during the estimated timeframe. Constant technological developments and budding adoption of advanced devices and well-equipped facilities that offer treatment for a wide range of ophthalmic diseases will drive the segment expansion between 2023-2032.
Considering the end-use, the others segment will grow considerably during the forecast period. Independent catheterization laboratories, physician's offices, multispecialty centers, and ablation centers are covered under the other segment. Increasing demand for multispecialty centers owing to their provision to offer specialized treatment for various medical conditions and superior quality of medical care will help the segment gain momentum through 2032 end.
Regionally, the Europe ablation device industry will be valued at over USD 5.5 billion by 2032. An increasing geriatric population base that is more susceptible to chronic diseases will stimulate the demand for ablation devices across the region. In addition, rising disposable income and high adoption of innovative technologies will further drive the European ablation devices market growth over the estimated timeframe.